WHO ICTRP trial

Randomized, open-label, parallel group, multi-centre Phase II clinical trial of…

EUCTR2011-004985-14-CZ · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2011-004985-14-CZ
Public title Randomized, open-label, parallel group, multi-centre Phase II clinical trial of active cellular immunotherapy DCVAC/PCa in patients with localized prostate cancer after primary radical prostatectomy
Scientific title Randomized, open-label, parallel-group, multi-centre phase II clinical trial of active cellular immunotherapy DCVAC/PCa in patients with localized prostate cancer after primary radical prostatectomy - not applicable
Primary sponsor Sotio a.s.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries Czech Republic
Conditions Localized prostate cancer after primary radical prostatectomy;Therapeutic area: Diseases [C] - Cancer [C04]
Interventions Product Name: DCVAC/PCa Product Code: DCVAC/PCa Pharmaceutical Form: Suspension for injection INN or Proposed INN: DCVAC/PCa Current Sponsor code: DCVAC/PCa Other descriptive name: DCVAC/PCa Concentration unit: Other Concentration type…
Registration date Nov 21, 2011
Secondary IDs SP003
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations